Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy
Alhossain A Khalafallah, Amanda E Dennis, Kath Ogden, Iain Robertson, Ruth H Charlton, Jackie M Bellette, Jessica L Shady, Nep Blesingk, Madeleine Ball, Alhossain A Khalafallah, Amanda E Dennis, Kath Ogden, Iain Robertson, Ruth H Charlton, Jackie M Bellette, Jessica L Shady, Nep Blesingk, Madeleine Ball
Abstract
Background: To date, there are no data available concerning the impact of iron therapy on the long-term well-being and health-related quality of life (HRQoL) in pregnancy.
Objective: To assess the long-term effect of iron therapy on HRQoL in pregnancy.
Design: This is a follow-up study conducted between January 2010 and January 2011 of an earlier randomised open-label clinical trial of intravenous and oral iron versus oral iron for pregnancy-related iron deficiency anaemia. We used a modified version of the SF-36 questionnaire together with the original prospective HRQoL data collected during and after pregnancy.
Participants and interventions: Of the original evaluable 183 pregnant Caucasian women randomised to receive oral iron or a single intravenous iron polymaltose infusion followed by oral iron maintenance, 126 women completed the follow-up HRQoL study.
Methods: The participants were followed up 4 weeks after treatment, predelivery and postdelivery for a median period of 32 months (range, 26-42) with a well-being and HRQoL questionnaire using a modified SF-36 QoL-survey and child growth charts as set by the Australasian Paediatric Endocrine Group (APEG).
Results: Patients who received intravenous iron demonstrated significantly higher haemoglobin and serum ferritin levels (p<0.001). There were strong associations between iron status and a number of the HRQoL parameters, with improved general health (p<0.001), improved vitality (physical energy) (p<0.001), less psychological downheartedness (p=0.005), less clinical depression (p=0.003) and overall improved mental health (p<0.001). The duration of breastfeeding was longer (p=0.046) in the intravenous iron group. The babies born in both groups recorded similarly on APEG growth chart assessments.
Conclusions: Our data suggest that HRQoL is improved until after pregnancy in anaemic pregnant women by repletion of their iron stores during pregnancy. About 80% of the intravenous iron group showed a maintained normal ferritin until delivery with long-term benefits. Further studies to confirm these findings are warranted.
Figures
References
- Allen L. Multiple micronutrients in pregnancy and lactation: an overview. Am J Clin Nutr 2005;81:1206S–12S
- Bashiri A, Burstein E, Sheiner E, et al. Anemia during pregnancy and treatment with intravenous iron: review of the literature. Eur J Obstet Gynecol Reprod Biol 2003;110:2–7
- Beard J. Effectiveness and strategies of iron supplementation during pregnancy. Am J Clin Nutr 2000;71:1288S–94S
- Allen L. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000;71:1280S–4S
- Scholl TO, Reilly T. Anemia, iron and pregnancy outcome. J Nutr 2000;130:443S–7S
- Rasmussen K. Is there a causal relationship between iron deficiency or iron-deficiency anemia and weight at birth, length of gestation and perinatal mortality? J Nutr 2001;13:590S–601S
- Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005;81:1218S–22S
- Beard J, Hendricks M, Perez E, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 2005;135:267–72
- Corwin E, Murray-Kolb L, Beard J. Low haemoglobin level is a risk factor for postpartum depression. J Nutr 2003;133:4139–42
- Makrides M, Crowther CA, Gibson RA, et al. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr 2003;78:145–53
- Allen L. Iron supplements: scientific issues concerning efficacy and implications for research and programs. J Nutr 2002;132:813S–19S
- Singh K, Fong YF, Kuperan P. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy. Eur J Haematol 1998;60:119–24
- Glare J. Clinical update: intravenous iron for anaemia. Lancet 2007;369:1502–4
- Khalafallah A, Dennis A, Bates J, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010;268:286–95; doi: 10.1111/j.1365–2796.2010.02251.x
- Reveiz L, Gyte GML, Cuervo LG. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2007;(2) CD003094 doi:
- Hurst NP, Ruta DA, Kind P. Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis. Br J Rheumatol 1998;37:862–9
- Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33
- Tarlov AR, Ware JE, Jr, Greenfield S, et al. The Medical Outcomes Study. JAMA 1989;262:925–30
- de Tychey C, Briançon S, Lighezzolo J, et al. Quality of life, postnatal depression and baby gender. J Clin Nurs 2008;17:312–22
- Jansen AJ, Duvekot JJ, Hop WC, et al. New insights into fatigue and health-related quality of life after delivery. Acta Obstet Gynecol Scand 2007;86:579–84
Source: PubMed